1-Aminomethyl-5-methoxyindane (AMMI), is a drug developed by a team led by David E. Nichols at Purdue University, which acts as a selective serotonin releasing agent (SSRA) and binds to the serotonin transporter (SERT) with similar affinity relative to DFMDA (Ki = 2,000nM).
See also Cyclized phenethylamine 1-Aminomethylindane (1-AMI) 2CB-Ind 1-Aminomethyl-6-methoxytetralin (AMMT) para-Methoxyamphetamine (PMA)
References
External links AMMI - Isomer Design